A 31-year-old man is urging people to recognise the five seemingly normal symptoms he experienced in the months leading up to ...

The study found that the five-year mortality rate was significantly lower among patients who were using GLP-1 receptor ...

Patients with colon cancer using GLP-1 receptor agonists (the class of drugs behind treatments like Ozempic, Wegovy, and ...

ROURKELA: A multi-institutional team led by the researchers of the National Institute of Technology- Rourkela (NIT-R) has ...

A UC San Diego study reveals GLP-1 receptor agonists, like Ozempic, may significantly reduce colon cancer death rates.

GLP-1 RAs are associated with a 62% reduction in 5-year mortality in colon cancer patients, especially those with high obesity. The study's findings remained significant after adjusting for ...

In the past decade, as the rate of colorectal cancer has dramatically increased among people under 50 years of age, ...

Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) use was significantly associated with a reduced odds of five-year mortality, but this protective effect was found to be statistically significant ...

The FDA has approved a groundbreaking blood test for colon cancer screening, offering a less invasive and more accessible ...

Police departments are using social media platforms to reach media outlets and the public more broadly. Canines, drones, and ...

Eating fibrous seasonal produce, such as Brussels sprouts and pumpkin, can help you stay regular and prevent constipation.

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...